Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Given the increasing exploration of fluorescent tracers in the field of nuclear medicine, a need has risen for practical development guidelines that can help improve the translation aspects of fluorescent tracers. This editorial discusses the does and don'ts in developing fluorescence tracers. It has been put forward by the European Association of Nuclear Medicine (EANM) Translational Molecular Imaging & Therapy committee and has been approved by the EANM board.

Original publication

DOI

10.1186/s41181-017-0034-8

Type

Journal article

Journal

EJNMMI Radiopharm Chem

Publication Date

2017

Volume

2

Keywords

Dual-modality, Fluorescence, Image guided surgery, Molecular imaging, Nuclear medicine, Tracers